<DOC>
	<DOCNO>NCT01948856</DOCNO>
	<brief_summary>The purpose study assess efficacy safety J022X ST prevention Recurrent Upper-Respiratory Tract Infections ( RURTI ) compare placebo child young age develop infectious disease frequently child age general .</brief_summary>
	<brief_title>CLEARI ( Clinical Efficacy Assessment Recurrent Upper-Respiratory Tract Infections ) Study</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>Key Patients follow criterion eligible inclusion Year 1 : Children , male female Aged 3 4 year Children know recurrent URTIs past year ( base medical recording report history ) Children risk URTI physician 's opinion ( e.g . absence breastfeeding , hospitalization previous year , tonsillectomy adenoidectomy , parental smoking , daycare institution nursery school , early schooling , prematurity , low weight birth , malnutrition , failure thrive ) . Patients follow criterion eligible randomisation Year 2 : Children , male female Aged 4 5 year Suffering RURTI , i.e . least 6 URTI episode medically confirm , maximum 18 , Year 1 study . Key Presence disease ( Chronic suppurative otitis medium , acute bronchopulmonary infection , Immune deficiency disorder , surgery respiratory tract , cystic fibrosisâ€¦ ) treatment ( chronic use corticosteroid , bronchodilator , ... ) may impact safety , interpretation result and/or participation subject study</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Recurrent common cold</keyword>
	<keyword>laryngitis</keyword>
	<keyword>pharyngitis/tonsillitis</keyword>
	<keyword>acute rhinitis</keyword>
	<keyword>acute rhinosinusitis</keyword>
	<keyword>acute otitis medium</keyword>
</DOC>